Summit Therapeutics
SMMT
$3.86
Share price
8.73%
Change (1 day)
192.42%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.20 B
According to Summit Therapeutics 's latest financial reports the company's total assets are $0.20 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Summit Therapeutics - Total assets on balance sheet (from 2020 to 2020)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.20 B | -69.44% |
| 2022-12-31 | $0.66 B | 485.82% |
| 2021-12-31 | $0.11 B | 10.61% |
| 2020-12-31 | $0.10 B | |
| 2019-01-31 | $0.10 B | -5.64% |
| 2018-01-31 | $0.11 B | 88.24% |
| 2017-01-31 | $58.72 M | 15.52% |
| 2016-01-31 | $50.83 M | 15.31% |
| 2015-01-31 | $44.09 M | 122.09% |
| 2014-01-31 | $19.85 M | 81.77% |
| 2013-01-31 | $10.92 M | 13.65% |
| 2012-01-31 | $9.61 M | -24.64% |
| 2011-01-31 | $12.75 M | -56.5% |
| 2010-01-31 | $29.31 M | 2.66% |
| 2009-01-31 | $28.55 M | -79.32% |
| 2008-01-31 | $0.13 B | 51.47% |
| 2007-01-31 | $91.18 M | 98.18% |
| 2006-01-31 | $46 M | -9.15% |
| 2005-01-31 | $50.64 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $3.26 B | 1,508.57% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $19.18 M | -90.55% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.62 B | 210.23% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |